Home > Products > CD19 & CD89
> Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Triple Body)
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Triple Body) (CAT#: TRIB-045)
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD19 antibody are both extended with the scFv fragment from an anti-CD89 antibody. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (Triple Body) (TRIB-045). Click the button below to contact us or submit your feedback about this product.